GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $668,000 | +2.0% | 15,340 | +3.3% | 0.06% | -1.7% |
| Q4 2021 | $655,000 | +17.6% | 14,852 | +1.9% | 0.06% | +5.5% |
| Q3 2021 | $557,000 | -4.0% | 14,571 | +0.0% | 0.06% | -3.5% |
| Q2 2021 | $580,000 | +3.2% | 14,564 | -7.4% | 0.06% | +1.8% |
| Q1 2021 | $562,000 | -1.9% | 15,734 | +1.1% | 0.06% | -5.1% |
| Q4 2020 | $573,000 | -12.8% | 15,562 | -10.8% | 0.06% | -19.2% |
| Q3 2020 | $657,000 | -3.7% | 17,447 | +4.4% | 0.07% | -11.0% |
| Q2 2020 | $682,000 | +7.7% | 16,712 | -0.0% | 0.08% | +34.4% |
| Q1 2020 | $633,000 | -7.7% | 16,718 | +14.5% | 0.06% | -33.7% |
| Q4 2019 | $686,000 | +15.3% | 14,601 | +4.8% | 0.09% | +19.5% |
| Q3 2019 | $595,000 | +4.2% | 13,936 | -2.3% | 0.08% | +5.5% |
| Q2 2019 | $571,000 | -8.1% | 14,271 | -4.0% | 0.07% | 0.0% |
| Q1 2019 | $621,000 | +31.8% | 14,871 | +20.6% | 0.07% | +19.7% |
| Q4 2018 | $471,000 | -51.4% | 12,332 | -48.9% | 0.06% | -45.5% |
| Q3 2018 | $969,000 | -7.5% | 24,113 | -7.3% | 0.11% | -15.2% |
| Q2 2018 | $1,048,000 | +24.2% | 25,998 | +20.4% | 0.13% | +18.9% |
| Q1 2018 | $844,000 | +14.4% | 21,596 | +3.8% | 0.11% | +12.1% |
| Q4 2017 | $738,000 | -25.1% | 20,799 | -14.3% | 0.10% | -1.0% |
| Q3 2017 | $985,000 | -23.8% | 24,270 | -19.1% | 0.10% | -28.6% |
| Q2 2017 | $1,293,000 | +6.0% | 29,989 | +3.6% | 0.14% | 0.0% |
| Q1 2017 | $1,220,000 | +18.2% | 28,934 | +7.9% | 0.14% | +0.7% |
| Q4 2016 | $1,032,000 | -17.3% | 26,804 | -7.4% | 0.14% | -1.4% |
| Q3 2016 | $1,248,000 | +0.6% | 28,947 | +1.2% | 0.14% | -0.7% |
| Q2 2016 | $1,240,000 | +8.6% | 28,608 | +1.6% | 0.14% | -44.1% |
| Q1 2016 | $1,142,000 | +2.5% | 28,161 | +2.0% | 0.25% | -9.6% |
| Q4 2015 | $1,114,000 | +7.7% | 27,598 | +2.6% | 0.28% | 0.0% |
| Q3 2015 | $1,034,000 | -1.5% | 26,905 | +6.8% | 0.28% | +1.4% |
| Q2 2015 | $1,050,000 | -4.6% | 25,200 | +5.6% | 0.28% | -14.8% |
| Q1 2015 | $1,101,000 | +26.3% | 23,867 | +17.0% | 0.32% | -0.6% |
| Q4 2014 | $872,000 | -6.6% | 20,394 | +0.3% | 0.33% | -14.6% |
| Q3 2014 | $934,000 | -9.8% | 20,327 | +4.9% | 0.38% | -18.9% |
| Q2 2014 | $1,036,000 | +9.3% | 19,379 | +9.2% | 0.47% | -18.9% |
| Q1 2014 | $948,000 | +174.0% | 17,745 | +173.6% | 0.58% | +116.4% |
| Q4 2013 | $346,000 | – | 6,486 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |